J.B. Chemicals' Panoli facility receives positive USFDA inspection

J.B. Chemicals & Pharmaceuticals (BSE: JBCHEPHARM) announced today that its API manufacturing facility located in Panoli, Gujarat, successfully completed a USFDA inspection conducted between March 10-13, 2025. The inspection concluded with the facility receiving "No Observations," resulting in no Form 483 being issued. The company emphasized its commitment to maintaining high standards of quality and compliance in all its markets through continuous investment in systems, processes, and employee training. Management stated it is committed to producing quality products and embedding a quality culture across the organization.